Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

HIV and associated infections

B Cybulska1

  • 1Department of Genitourinary Medicine, St. Thomas's Hospital, London.

Journal of the Royal College of Physicians of London
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Understanding opportunistic infections in human immunodeficiency virus (HIV) is key. Research focuses on pathogenesis, diagnostics, and therapies to improve patient survival and combat AIDS progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Treatment of dyslipidemia. Progress in cardiologic practice].

Polskie Archiwum Medycyny Wewnetrznej·2002
Same author

MFAME, N-methyl-N-D-fructosyl amphotericin B methyl ester, a new amphotericin B derivative of low toxicity: relationship between self-association and effects on red blood cells.

Biochimica et biophysica acta·2001
Same author

Helping the woman with sexual dysfunction.

The Practitioner·2001
Same author

[Micronized fenofibrate, decreased triglyceride levels, total cholesterol and LDL fractions in serum].

Polskie Archiwum Medycyny Wewnetrznej·2001
Same author

N-Methyl-N-D-fructosyl amphotericin B methyl ester (MF-AME), a novel antifungal agent of low toxicity: monomer/micelle control over selective toxicity.

Acta biochimica Polonica·2000
Same author

Comparative studies on cell stimulatory, permeabilizing and toxic effects induced in sensitive and multidrug resistant fungal strains by amphotericin B (AMB) and N-methyl-N-D-fructosyl amphotericin B methyl ester (MFAME).

Acta biochimica Polonica·2000
Same journal

A Change of Government and Its Effect on the NHS Hospital Outpatient Service.

Journal of the Royal College of Physicians of London·2019
Same journal

Erratum: Model for the Organisation of a Community-Based Rehabilitation Service.

Journal of the Royal College of Physicians of London·2019
Same journal

Telemedicine and beyond.

Journal of the Royal College of Physicians of London·2019
Same journal

Palliative Care in General Medicine.

Journal of the Royal College of Physicians of London·2019
Same journal

Medical Negligence.

Journal of the Royal College of Physicians of London·2019
Same journal

In Response.

Journal of the Royal College of Physicians of London·2019
See all related articles

Area of Science:

  • Infectious Diseases
  • Virology
  • Immunology

Background:

  • Human immunodeficiency virus (HIV) infection leads to acquired human immunodeficiency syndrome (AIDS).
  • Opportunistic infections are a major concern in managing HIV/AIDS patients.
  • The role of associated infections in HIV progression is increasingly understood.

Purpose of the Study:

  • To discuss the pathogenesis and interactions of opportunistic infections with HIV.
  • To explore the application of this knowledge in diagnostic and therapeutic procedures.
  • To review advancements in antiviral therapies and multidrug treatment strategies for HIV/AIDS.

Main Methods:

  • Conference proceedings and expert discussions.
  • Review of current understanding of HIV pathogenesis and opportunistic infections.

Related Experiment Videos

  • Exploration of emerging diagnostic and therapeutic approaches.

    • Main Results:

    • Understanding of HIV-associated infections is improving.
    • Prophylaxis strategies for opportunistic infections are becoming viable.
    • Antiviral therapies show potential for prolonging survival in HIV patients.

    Conclusions:

    • Multidrug therapy is likely the future of HIV/AIDS treatment.
    • Continued research into pathogenesis and interactions is crucial for improved management.
    • Focus on diagnostics and therapeutics will enhance patient outcomes and survival.